Following trials, Moderna has announced the vaccine shows a strong immune response in children under the age of 12.
This is based on phase 2 of a three phase trial with 4,750 children. The results also show that the immune response is even stronger in children than it is in adults.
Symptoms included fatigue, headache, fever, and injection pain.
The results will be submitted for peer review as the FDA starts their discussion on EUA for children to get lower doses of the Pfizer vaccine.
Make FL1 part of your day.
Local reporting. Useful updates. More ways to stay close to your community.
Go ad-free
Support independent local reporting and enjoy FL1 without display ads.
$4.99 / month
Become a member →Cancel anytime. Third-party media players may contain ads.Get the daily briefing
Start your morning with the headlines that matter across the Finger Lakes.
Find more FL1 on Google
Choose FingerLakes1.com as a preferred source to see more of our reporting in your Google news results.





